论文信息 - First-in-human Intravesical Delivery of Pembrolizumab Identifies Immune Activation in Bladder Cancer Unresponsive to Bacillus Calmette-Guérin. - 字舞流文

First-in-human Intravesical Delivery of Pembrolizumab Identifies Immune Activation in Bladder Cancer Unresponsive to Bacillus Calmette-Guérin.

J. Meeks | M. Kocherginsky | S. Swaminathan | R. Svatek | B. Choy | L. Cooley | Khyati Meghani | Sabah S. Munir | Timothy K. Kuzel | Sabah Munir | K. Meghani